16. April 2020 | 07:55 CET
Johnson & Johnson, Memphasys, Procter & Gamble - for a better life
Good health is a valuable possession. Small and large companies around the globe are engaged in research and development to make people's lives easier or better through modern and innovative products and solutions. The consumer goods and pharmaceutical sectors often offer attractive opportunities for investors to generate a lucrative return. Well-known companies with established brands usually ensure lasting sales. However, promising young companies also use innovations to attract the attention of investors and customers.
time to read:
1 minutes
by
Mario Hose
ISIN:
US4781601046 , AU000000MEM5 , US7427181091
Author
Mario Hose
Born and raised in Hannover, Lower Saxony follows social and economic developments around the globe. As a passionate entrepreneur and columnist he explains and compares the most diverse business models as well as markets for interested stock traders.
Innovation helps with the desire for children
Memphasys from Australia deals with the subject of in-vitro fertilization. The target groups are couples who wish to have children but have not yet been able to achieve a successful pregnancy by natural means. The company has developed a product called FELIX, which is used in the field of bio-separation of sperm. With this innovation, the particularly promising sperm cells are separated from the seminal fluid in just a few minutes to increase the chances of a successful pregnancy. Initially, the focus is on artificial insemination of humans, but in the future animals will also be accompanied.
Alison Coutts is Executive Chairman of Memphasys and explains the product and future areas of application in a video - youtu.be/kHA-UhbeZH8. FELIX is expected to be launched in the second half of 2020. The company currently has a market capitalization of around AUD 35 million and a successful market launch offers corresponding potential for the shares.
Group with brands
Johnson & Johnson is a broad-based group from the USA and is a member of the Dow Jones Index. The market value of the company is around USD 390 billion. Johnson & Johnson products are available under various brands worldwide and can be found in virtually every household. The pharmaceutical and consumer goods manufacturer has a highly diversified product universe and can therefore benefit from a variety of revenue streams. Optimal conditions for conservative investors.
Dividend stock with consumer goods
Procter & Gamble is also a member of the Dow Jones Index and has a market capitalization of approximately USD 300 billion. The manufacturer of consumer goods can also offer a wide range of products from around the world on the shelves of drugstores and supermarkets. The company aims to improve the lives of its customers with products in the Care, Hygiene, Healthcare and Household segments. Due to the size of the company and the diversity of its product range, the dividend stock can build on numerous revenue streams and drive development.
